Agilent Technologies, Inc. (a) Initiated at Neutral with $150 Price Target by Piper Sandler

We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Agilent Technologies, Inc. (NYSE:A) is among the best healthcare stocks TheFly reported on June 11 that Piper Sandler began coverage of A with a Neutral rating and

We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts.

Agilent Technologies, Inc. (NYSE:A) is among the best healthcare stocks

TheFly reported on June 11 that Piper Sandler began coverage of A with a Neutral rating and established a $150.00 price target. The firm initiated coverage of the life science tools sector, noting that it prefers to wait for clearer signs of future growth drivers before becoming more positive on additional companies in the space. Piper Sandler highlighted that challenges related to biotech and academic spending, along with China-related exposure, could improve in the near term.

Separately, on June 3, Agilent Technologies, Inc. (NYSE:A) announced a strategic collaboration with OpenAI and Boston Consulting Group (BCG) to expand the use of artificial intelligence across its business operations, product development, and customer solutions. The partnership aims to strengthen the business’s AI capabilities by improving the integration of advanced technologies into its instruments, software, and services. Through this collaboration, the corporation plans to accelerate AI adoption throughout the company while enhancing its ability to deliver faster and more accurate insights for customers.

Leave a Reply

Your email address will not be published. Required fields are marked *